SEARCH

SEARCH BY CITATION

References

  • Bar-Peled, M., Griffith, C.L., and Doering, T.L. (2001) Functional cloning and characterization of a UDP-glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Proc Natl Acad Sci USA 98: 1200312008.
  • Bernard, M., and Latgé, J.-P. (2001) Aspergillus fumigatus cell wall: composition and biosynthesis. Med Mycol 39: 917.
  • Borges-Walmsley, M., Chen, D., Shu, X., and Walmsley, A. (2002) The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol 10: 8087.
  • Bose, I., Reese, A.J., Ory, J.J., Janbon, G., and Doering, T.L. (October 2003) Eukaryot Cell 2: 655663.
  • Brandhorst, T., and Klein, B.L. (2001) Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of virulence-associated adhesin via extracellular release and reassociation with cell wall chitin. J Biol Chem 275: 79257934.
  • Brown, T., and Mackey, K. (2001) Unit 4.9. Analysis of RNA by Northern and slot blot hybridization. In Current Protocols in Molecular Biology, Suppl. 37. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (eds). New York: John Wiley & Sons, pp. 4.9.14.9.8.
  • Buchanan, K.L., and Murphy, J.W. (1998) What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 4: 7183.
  • Bulmer, G.S., and Sans, M.D. (1968) Cryptococcus neoformans. III. Inhibition of phagocytosis. J Bacteriol 95: 58.
  • Cabib, E., Bowers, B., Sburlati, A., and Silverman, S. (1988) Fungal cell wall synthesis: the construction of a biological structure. Microbiol Sci 5: 370375.
  • Cabib, E., Roh, D., Schmidt, M., Crotti, L., and Varma, A. (2001) The yeast cell wall and septum as paradigms of cell growth and morphogenesis. J Biol Chem 276: 1967919682.
  • Casadevall, A., and Perfect, J.R. (1998) Cryptococcus neoformans. Washington, DC: American Society for Microbiology Press.
  • Casadevall, A., Mukherjee, J., Devi, S.J.N., Schneerson, R., Robbins, J.B., and Scharff, M.D. (1992) Antibodies elicited by a Cryptococcus neoformans–Tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. Emerg Infect Dis 165: 10861093.
  • Chanda, V.B. (2001) Unit 13.1. Preparation of yeast media. In Current Protocols in Molecular Biology, Suppl. 23. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (eds). New York: John Wiley & Sons, pp. 13.11.12.
  • Chang, Y., and Kwon-Chung, K. (1994) Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14: 49124919.
  • Chang, Y., and Kwon-Chung, K. (1998) Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun 66: 22302236.
  • Chang, Y., and Kwon-Chung, K. (1999) Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol 181: 56365643.
  • Chang, Y.C., Cherniak, R., Kozel, T.R., Granger, D.L., Morris, L.C., Weinhold, L.C., and Kwon-Chung, K.J. (1997) Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene. Infect Immun 65: 15841592.
  • Cherniak, R., Valafar, H., Morris, L.C., and Valafar, F. (1998) Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5: 146159.
  • Cottrell, T.R., and Doering, T.L. (October 2003) Silence of the strands: RNA interference in eukaryotic pathogens. Trends Microbiol 11: 3743.
  • Eissenberg, L.G., and Goldman, W.E. (1987) Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect Immun 55: 2934.
  • Eissenberg, L.G., Moser, S.A., and Goldman, W.E. (1997) Alterations to the cell wall of Histoplasma capsulatum yeasts during infection of macrophages or epithelial cells. J Infect Dis 175: 15381544.
  • Flicek, P., Keibler, E., Hu, P., Korf, I., and Brent, M.R. (October 2003) Leveraging the mouse genome for gene prediction in human: from whole-genome shotgun reads to a global synteny map. Genome Res 13: 4654.
  • De Groot, P.W.J., Ruiz, C., Aldana, C.R.V.D., Dueas, E., Cid, V.J., Rey, F.D., et al. (2001) A genomic approach for the identification and classification of genes involved in cell wall formation and its regulation in Saccharomyces cerevisiae. Comp Funct Genom 2: 124142.
  • Hammond, S.M., Caudy, A.A., and Hannon, G.J. (2001) Post-transcriptional gene silencing by double-stranded RNA. Nature Rev Genet 2: 110119.
  • Hannon, G.J. (2002) RNA interference. Nature Genet 418: 244251.
  • Hochstenbach, F., Klis, F.M., Van Den Ende, H., Van Donselaar, E., Peters, P.J., and Klausner, R.D. (1998) Identification of a putative alpha-glucan synthase essential for cell wall construction and morphogenesis in fission yeast. Proc Natl Acad Sci USA 95: 91619166.
  • Hogan, L.H., and Klein, B.S. (1994) Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect Immun 62: 35433546.
  • James, P.G., Cherniak, R., Jones, R.G., Stortz, C.A., and Reiss, E. (1990) Cell-wall glucans of Cryptococcus neoformans CAP67. Carbohydr Res 198: 2338.
  • Kapteyn, J.C., Hoyer, L.L., Hecht, J.E., Müller, W.H., Andel, A., Verkleij, A.J., et al. (2000) The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants. Mol Microbiol 35: 601611.
  • Katayama, S., Hirata, D., Arellano, M., Pérez, P., and Toda, T. (1999) Fission yeast alpha-glucan synthase Mok1 requires the actin cytoskeleton to localize the sites of growth and plays an essential role in cell morphogenesis downstream of protein kinase C function. J Cell Biol 144: 11731186.
  • Klimpel, K.R., and Goldman, W.E. (1988) Cell walls from avirulent variants of Histoplasma capsulatum lack alpha-(1,3)-glucan. Infect Immun 56: 29973000.
  • Klis, F.M., De Groot, P., and Hellingwerf, K. (2001) Molecular organization of the cell wall of Candida albicans. Med Mycol 39: 18.
  • Kozel, T.R. (1977) Non-encapsulated variant of Cryptococcus neoformans II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect Immun 16: 99106.
  • Kozel, T.R. (1995) Virulence factors of Cryptococcus neoformans. Trends Microbiol 3: 295298.
  • Kozel, T.R., and Hermerath, C.A. (1984) Binding of cryptococcal polysaccharide to Cryptococcus neoformans. Infect Immun 43: 879886.
  • Kurtz, M.B., and Rex, J.H. (2001) Glucan synthase inhibitors as antifungal agents. Adv Protein Chem 56: 423475.
  • Lipke, P.N., and Ovalle, R. (1998) Cell wall architecture in yeast: new structure and new challenges. J Bacteriol 180: 37353740.
  • Liu, H., Cottrell, T.R., Pierini, L.M., Goldman, W.E., and Doering, T.L. (2002) RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics 160: 463470.
  • MacGill, T.C., MacGill, R.S., Casadevall, A., and Kozel, T.R. (2000) Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans. J Immunol 164: 48354842.
  • Moyrand, F., Klaproth, B., Himmelreich, U., Dromer, F., and Janbon, G. (2002) Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol Microbiol 43: 837849.
  • Pierini, L.M., and Doering, T.L. (2001) Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol Microbiol 41: 105115.
  • Sakaguchi, N., Baba, T., Fukuzawa, M., and Ohno, S. (1993) Ultrastructural study of Cryptococcus neoformans by quick-freezing and deep-etching method. Mycopathologia 121: 133141.
  • Small, J.A., and Mitchell, T.G. (1986) Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants. Infect Immun 54: 742750.
  • Smits, G.J., Kapteyn, J.C., Ende, H.V.D., and Klis, F.M. (1999) Cell wall dynamics in yeast. Curr Opin Microbiol 2: 348352.
  • Sommer, U., Liu, H., and Doering, T.L. (October 2003) An α-1,3-mannosyltransferase of Cryptococcus neoformans. J Biol Chem doi:10.1074/jbc.M307223200 (in press).
  • Tacker, J.R., Farhi, F., and Bulmer, G.S. (1972) Intracellular fate of Cryptococcus neoformans. Infect Immun 6: 162167.
  • Tsumori, H., Shimamura, A., and Mukasa, H. (1985) Purification and properties of extracellular glucosyltransferase synthesizing 1,3-alpha-d-glucan from Streptococcus mutans serotype a. J Gen Microbiol 131: 553559.
  • Vaishnav, V.V., Bacon, B.E., O'Neill, M., and Cherniak, R. (1998) Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res 306: 315330.
  • Wiater, A., Choma, A., and Szczodrak, J. (1999) Insoluble glucans synthesized by cariogenic streptococci: a structural study. J Basic Microbiol 39: 265273.
  • Wickes, B.L., and Edman, J.C. (1994) Development of a transformation system for Cryptococcus neoformans. In Molecular Biology of Pathogenic Fungi: a Laboratory Manual. Maresca, B., And Kobayashi, , G.C. (eds). New York: Telos Press, pp. 309313.
  • Wickes, B.L., Edman, U., and Edman, J. (1997) The Cryptococcus neoformans STE12alpha gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific. Mol Microbiol 26: 951960.
  • Wills, E.A., Roberts, I.S., Poeta, M.D., Rivera, J., Casadevall, A., Cox, G.M., and Perfect, J.R. (2001) Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol Microbiol 40: 610620.